Regulations/Legal

Latest Issue of OR Manager
February 2025
Home Regulations/Legal

FDA: Class I recall of Medtronic Synergy Cranial, StealthStation S7 cranial software

Editor's Note The Food and Drug Administration (FDA) on January 6 identified the recall by Medtronic of its Stealth Station System with Synergy Cranial and StealthStation S7 Cranial Software as Class I, the most serious. The System aids in precisely locating anatomical structures in neurosurgical procedures. The recall was initiated…

Read More

By: Judy Mathias
January 18, 2022
Share

Supreme Court blocks federal government’s vaccine mandate for large workplaces but not for healthcare facilities

Editor's Note The Supreme Court on January 13 blocked the federal government’s COVID-19 vaccine-or-test requirement for workplaces with 100 or more employees, but the Court is allowing a vaccine mandate for healthcare workers at facilities that receive Medicaid and Medicare funds. The order covers more than 17 million healthcare workers…

Read More

By: Judy Mathias
January 13, 2022
Share

NIOSH rescinds approval for ALG Health’s N95 respirator masks

Editor's Note The National Institute for Occupational Safety and Health (NIOSH) has honored a request by N95 respirator mask manufacturer, ALG Health (Bryan, Ohio), to rescind all respirator approvals issued to ALG Health, effective immediately. As of January 6, any of the following ALG Health N95 respirators marked with a…

Read More

By: Judy Mathias
January 13, 2022
Share

The Joint Commission revises requirements for informed consent, AV information

Editor's Note The Joint Commission, on January 12, announced that revisions to the Rights and Responsibilities of the Individual (RI) chapter addressing the written policy on informed consent and organizational use of images, films, and recording of patients will become effective July 1, 2022. Among the revisions: A new bullet…

Read More

By: Judy Mathias
January 13, 2022
Share

Sponsored Message

FDA: Class I recall of Cardiovascular Systems’ WIRION Embolic Protection Device

Editor's Note The Food and Drug Administration (FDA), on January 10, identified the recall of Cardiovascular Systems’ WIRION Embolic Protection Device as Class I, the most serious. The device, which is used to hold or remove debris or blood clots from the lower limbs, was recalled because of complaints of…

Read More

By: Judy Mathias
January 11, 2022
Share

The Joint Commission implements some off-site processes for DSC on-site reviews

Editor's Note The Joint Commission announced January 5, 2022, that, effective immediately, all disease-specific care (DSC) on-site reviews will implement a portion of the off-site review process developed in response to the COVID-19 pandemic. The off-site review process required organizations to upload documentation before the scheduled review, which organizations told…

Read More

By: Judy Mathias
January 6, 2022
Share

Sponsored Message

FDA: Class I recall of Puritan Bennett 980 Series Ventilator

Editor's Note The Food and Drug Administration (FDA), on January 3, identified the recall by Covidien of its Puritan Bennett 980 Series Ventilator as Class I, the most serious. The recall was initiated because of a capacitor manufacturing assembly error that may cause the ventilator to become inoperable or stop…

Read More

By: Judy Mathias
January 5, 2022
Share

Meta-analysis finds high global percentage of asymptomatic COVID-19 infections

Editor's Note This study by Chinese researchers finds a high percentage of asymptomatic COVID-19 infections worldwide, which highlights the potential transmission risk of asymptomatic infections in communities. In this review and meta-analysis of 95 studies, which include nearly 30 million individuals undergoing testing, the percentage of asymptomatic infections was 0.25%…

Read More

By: Judy Mathias
December 16, 2021
Share

FDA: Class I recall of Getinge/Datascope/Maquet Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps

Editor's Note The Food and Drug Administration, on December 16, identified the recall by Getinge/Datascope/Maquet of its Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The IABPs are cardiac assist devices used in patients having cardiac and noncardiac surgery and to treat patients…

Read More

By: Judy Mathias
December 16, 2021
Share

Effectiveness of mRNA vaccines against COVID-19

Editor's Note This case-controlled study by researchers from White River Junction Veterans Affairs Medical Center, White River Junction, Vermont, and Dartmouth School of Medicine, Hanover, New Hampshire, finds that mRNA vaccine effectiveness against COVID-19 decreases significantly after about 6 months. In this analysis of 14,238 male veterans aged 65 or…

Read More

By: Judy Mathias
December 16, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat